Skip to content

Studies and technological development of intestinal blood flow quantification by abdominal ultrasound in children.

Studies and technological development of intestinal blood flow quantification by abdominal ultrasound in children. - Studies and technological development of intestinal blood flow quantification by abdominal ultrasound in children.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011874
Enrollment
110
Registered
2013-10-01
Start date
2013-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric gastrointestinal disease

Interventions

Normal control group (non-gastrointestinal disease group) Gastrointestinal disease group

Sponsors

Hitachi, Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Food protein induced enterocolitis syndrome (FPIES) infants from 0-day-old to 1 month of age. 2. Pediatric gastrointestinal disease including infectious enterocolitis and inflammatory bowel disease from 0-day-old to 16-year-old. 3. The normal control is the children who have no abnormal findings in abdominal clinical examination and ultrasound.

Exclusion criteria

Exclusion criteria: Children with intensive body motion who do not allow us to take clear ultrasound image.

Design outcomes

Primary

MeasureTime frame
Intestinal blood flow volume of gastrointestinal disease and normal control. (1. Gastric antrum, 2. Duodenum, 3. Jejunum, 4. Terminal ileum, 5. Ileocecal, 6.Sigmoid colon)

Countries

Japan

Contacts

Public ContactKeisuke Jimbo

Juntendo University Graduate School of Medicine Pediatrics and Adolescent Medicine

kjinbo@juntendo.ac.jp03-3813-3111(3325)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026